In Summary, the authors identified two key genes (PMAIP1 and PPA2) that are closely associated with mitochondrial metabolism in AD and can differentiate AD patients from controls and are thus potential mitochondrial metabolism-related biomarkers for disease diagnosis and therapeutic monitoring. Here, PPA2 is linked to Alzheimer disease.